A study titled "Polyol-Functionalized Manganese-Based Nanoparticles: From Insulin Amyloid Inhibition to Nanozyme-Mediated Antioxidant Activity" was published on September 18, 2026. The paper appears in the International Journal of Molecular Sciences. The publication relates to insulin, an approved compound, in the context of amyloid inhibition and nanozyme-mediated antioxidant activity. No findings or results from the study were provided beyond the title and publication details. This entry reflects only that the publication exists and its stated subject matter. No efficacy, safety, or outcome data from the study are described here. Readers interested in the underlying research should consult the original publication for full details, methodology, and results. For general background on insulin aspart, including its approved regulatory status and typical use, see the compound overview.
Publication Examines Insulin Aspart Amyloid Inhibition via Nanoparticles
See the full insulin aspart overview
Source: https://pubmed.ncbi.nlm.nih.gov/42794748/